| Original language | English |
|---|---|
| Pages (from-to) | 479 - 479 |
| Number of pages | 1 |
| Journal | Medical Journal of Australia |
| Volume | 202 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 2015 |
Cite this
@article{a4bcdbb46084432a8d8638b97ce103c4,
title = "HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths",
author = "William Sievert",
year = "2015",
doi = "10.5694/mja15.00165",
language = "English",
volume = "202",
pages = "479 -- 479",
journal = "Medical Journal of Australia",
issn = "0025-729X",
publisher = "AMPCo",
number = "9",
}
Sievert, W 2015, 'HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths', Medical Journal of Australia, vol. 202, no. 9, pp. 479 - 479. https://doi.org/10.5694/mja15.00165
HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths. / Sievert, William.
In: Medical Journal of Australia, Vol. 202, No. 9, 2015, p. 479 - 479.Research output: Contribution to journal › Letter › Other
TY - JOUR
T1 - HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths
AU - Sievert, William
PY - 2015
Y1 - 2015
UR - https://www.mja.com.au/system/files/issues/202_09/letters_180515.pdf
U2 - 10.5694/mja15.00165
DO - 10.5694/mja15.00165
M3 - Letter
VL - 202
SP - 479
EP - 479
JO - Medical Journal of Australia
JF - Medical Journal of Australia
SN - 0025-729X
IS - 9
ER -